COVID-19 Collection

Journal article

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

Abstract:: Background The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to investigate transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community.
Methods Between Sept 13, 2020, and Sept 15, 2021, 602 community contacts (identified via the UK contract-tracing system) of 471 UK COVID-19 inde... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Singanayagam, A., Hakki, S., Dunning, J., Madon, K. J., Crone, M. A., Koycheva, A., Derqui-Fernandez, N., Barnett, J. L., Whitfield, M. G., Varro, R., Charlett, A., Kundu, R., Fenn, J., Cutajar, J., Quinn, V., Conibear, E., Barclay, W., Freemont, P. S., Taylor, G. P., … Lalvani, A. (2021). Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infectious Diseases, 22(2), 183–195.

MLA Style

Singanayagam, A, et al. “Community Transmission and Viral Load Kinetics of the SARS-CoV-2 Delta (B.1.617.2) Variant in Vaccinated and Unvaccinated Individuals in the UK: a Prospective, Longitudinal, Cohort Study.” Lancet Infectious Diseases, vol. 22, no. 2, 2021, pp. 183–95.

Chicago Style

Singanayagam, A, S Hakki, J Dunning, et al. 2021. “Community Transmission and Viral Load Kinetics of the SARS-CoV-2 Delta (B.1.617.2) Variant in Vaccinated and Unvaccinated Individuals in the UK: a Prospective, Longitudinal, Cohort Study.” Lancet Infectious Diseases 22 (2): 183–95.
Print

Access Document

Files:: Singanayagam_et_al_2021_Community_transmission_and.pdf

(Preview, Version of record, pdf, 1.8MB, Terms of use)

Publisher copy:: 10.1016/S1473-3099(21)00648-4

Authors

+ Singanayagam, A More by this author

Role:: Author

+ Hakki, S More by this author

Role:: Author

+ Dunning, J More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: Tropical Medicine
Role:: Author
ORCID:: 0000-0002-4035-4562

+ Madon, KJ More by this author

Role:: Author

+ Crone, MA More by this author

Role:: Author

More authors...

Contributors

+ ATACCC Study Investigators

Role:: Contributor

Publisher:: Elsevier
Journal:: Lancet Infectious Diseases More from this journal
Volume:: 22
Issue:: 2
Pages:: 183-195
Publication date:: 2021-10-28
Acceptance date:: 2021-10-11
DOI:: 10.1016/S1473-3099(21)00648-4
EISSN:: 1474-4457
ISSN:: 1473-3099

Language:: English
Keywords:: FFR
Pubs id:: 1206031
Local pid:: pubs:1206031
Deposit date:: 2021-11-30
ARK identifier:: ark:/29072/ora_5d4cfa750c3e4da3b42d0ca3173a400f

Terms of use

Copyright holder:: Singanayagam et al
Copyright date:: 2021
Rights statement:: © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.

Licence:: CC Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP